Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$9.03 - $21.55 $677 - $1,616
-75 Closed
0 $0
Q1 2022

Apr 28, 2022

BUY
$15.0 - $22.83 $1,125 - $1,712
75 New
75 $2,000
Q4 2019

Jan 30, 2020

SELL
$4.05 - $14.61 $1,620 - $5,844
-400 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$7.04 - $11.77 $2,816 - $4,708
400 New
400 $3,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $9.53M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.